Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies

Background  Thromboembolism remains a detrimental complication of novel coronavirus disease (COVID-19) despite the use of prophylactic doses of anticoagulation Objectives  This study aimed to compare different thromboprophylaxis strategies in COVID-19 patients Methods  We conducted a systematic data...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsebaie, Maha A. T., Baral, Binav, Elsebaie, Mai, Shrivastava, Trilok, Weir, Catherine, Kumi, Dennis, Birch, Noah W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581586/
https://www.ncbi.nlm.nih.gov/pubmed/36299621
http://dx.doi.org/10.1055/a-1930-6492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581586/
https://www.ncbi.nlm.nih.gov/pubmed/36299621
http://dx.doi.org/10.1055/a-1930-6492

Ejemplares similares